Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
5.78
+0.04 (0.70%)
Nov 2, 2026, 12:23 PM EST - Market open

Phathom Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-83-221.25-334.33-201.59-197.72-143.88
Depreciation & Amortization
0.470.630.80.580.620.52
Other Amortization
3.523.012.191.882.113.6
Stock-Based Compensation
23.7828.7224.0545.0324.1316.81
Other Operating Activities
22.2234.4855.8230.1818.891.81
Change in Accounts Receivable
-51.81-39.33-37.16-1.64--
Change in Inventory
-7.63-11.78-6.14-9.44--
Change in Accounts Payable
68.8134.134.946.418.68-9.79
Change in Other Net Operating Assets
2.914.63-6.93-8.98-3.24-17.52
Operating Cash Flow
-20.74-166.78-266.77-137.58-146.53-148.46
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.3-0.23-0.14-1.63-1.04-0.33
Investing Cash Flow
-0.3-0.23-0.14-1.63-1.04-0.33

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--59.4211.9995.4596.89
Total Debt Issued
173.25-59.4211.9995.4596.89
Long-Term Debt Repaid
------54.13
Net Debt Issued (Repaid)
-55.8-59.4211.9995.4542.76
Issuance of Common Stock
127.751.64123.37155.5924.61.94
Repurchase of Common Stock
-1.51-1.93----
Financing Cash Flow
70.45-0.29182.77367.58120.0444.71

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
49.4-167.29-84.13228.37-27.53-104.08

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-21.04-167-266.91-139.21-147.57-148.79
Free Cash Flow Growth
------
Free Cash Flow Margin
-7.66%-95.37%-483.07%-20412.61%--
Free Cash Flow Per Share
-0.26-2.29-4.22-2.71-3.77-4.02
Levered Free Cash Flow
-12.94-107.86-203.85-90.45-93.78-96.73
Unlevered Free Cash Flow
22.73-68.3-161.04-66.1-78.83-96.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
19.1521.3717.2911.137.034.07
Change in Working Capital
12.28-12.38-15.3-13.645.44-27.32
SEC Filings: 10-K · 10-Q